A股三大指数今日涨跌不一，截至收盘，沪指涨0.16%报3876.37点，深证成指跌1.29%，创业板指跌 2.17%，北证50跌0.51%。全市场成交额16722亿元，较上日成交额缩量1621亿元，超2800股上涨。 盘面上，医药商业板块大涨，漱玉平民、华人健康20cm涨停；商业航天产业迎来政策与技术双重催 化，相关概念股现涨停潮，顺灏股份、北摩高科、西部材料等涨停；银行股全线上涨，上海银行、渝农 银行涨超3%；IP经济、军工装备、零售板块涨幅居前。另外，海南本地股集体调整，罗牛山、海马汽 车跌超9%：元件板块持续走低，山东精密跌超6%；电池股普跌，华盛锂电跌超10%，海科新源跌超 7%。(格隆汇) ...

Core Viewpoint - Shenzhen Shangshui Intelligent Co., Ltd. has applied for IPO on the Shenzhen Stock Exchange's Growth Enterprise Market, aiming to raise approximately 587.39 million yuan, with a focus on the intelligent equipment industry, particularly in the fields of new energy battery and new material preparation [1] Group 1: Company Overview - The company has over ten years of experience in the intelligent equipment industry, developing a comprehensive technical capability system based on "core single machine + intelligent control system + process package" [1] - Main business activities include micro-nano powder processing, precise measurement of powder-liquid, powder-liquid mixing and dispersion, and functional film preparation, with applications across various sectors such as new energy batteries, new materials, chemicals, food, pharmaceuticals, and semiconductors [1] Group 2: Market Position and Products - In the new energy battery electrode manufacturing sector, the company has developed a high-efficiency pulping system that significantly enhances slurry consistency, efficiency, and energy efficiency, achieving a 60% market share in China, ranking first [2] - The company has established partnerships with major players in the new energy battery and vehicle sectors, including BYD, CATL, and Samsung SDI, among others [2] Group 3: New Material Preparation - The company has a systematic layout for micro-nano material processing, including mixing, dispersion, grinding, coating, drying, and film preparation, forming a smart equipment system with delivery capabilities [3] - Products are utilized in various applications, including new energy battery materials, functional films, semiconductor packaging materials, and functional ceramics, serving clients such as BETTERI and Wanhua Chemical [3] Group 4: Financial Performance - The company reported revenues of approximately 397.7 million yuan, 601 million yuan, 637 million yuan, and 398 million yuan for the years 2022, 2023, 2024, and the first half of 2025, respectively [3] - Net profits for the same periods were approximately 97.72 million yuan, 234 million yuan, 153 million yuan, and 93.71 million yuan [3] - Total assets increased from 1.356 billion yuan in 2022 to 2.049 billion yuan by June 30, 2025, while the equity attributable to the parent company rose from 181.94 million yuan to 665.63 million yuan during the same period [4]

Core Viewpoint - Kolonbo Tai has reached a settlement agreement with Yilian Bio and its key personnel to resolve previous disputes, aiming to save litigation time and costs [1] Group 1: Settlement Agreement - The settlement involves Yilian Bio sharing revenue and net profits from six products (YL201, YL202, YL211, YL212, YL221, YL222) with Kolonbo Tai [1] - Kolonbo Tai stated that the settlement aligns with the overall interests of the company and its shareholders, and will not significantly impact the group's financial status or operations [1] Group 2: Background of the Dispute - The dispute originated from Kolonbo Tai's criminal complaint against Yilian Bio in 2024 and subsequent civil lawsuits in 2025 regarding alleged commercial secret infringements [1][2] - Key executives of Yilian Bio, including its founder and CEO, have previous ties to Kolonbo Tai, which may have contributed to the disputes [2][3] Group 3: Product Development and Collaborations - Yilian Bio's product YL201 is in Phase III clinical trials and received breakthrough therapy designation from the FDA for small cell lung cancer [6] - The company has established significant collaborations, including a global partnership with Roche for YL211, which includes a $50 million upfront payment and potential milestone payments nearing $1 billion [6][7] - Yilian Bio has also engaged in multiple strategic collaborations with BioNTech and Zai Lab, indicating strong business development activity [7] Group 4: Market Context and Future Prospects - The rapid resolution of the dispute may be linked to Yilian Bio's plans for an IPO, as resolving intellectual property issues is crucial for the approval process [2][8] - The current hot market for Hong Kong IPOs suggests that Yilian Bio could aim for a 2026 listing, emphasizing the importance of business development capabilities and clinical progress [8]

Market Overview - A-shares showed significant divergence with the Shanghai Composite Index rising by 0.16% to 3876.37 points, while the Shenzhen Component Index fell by 1.29% and the ChiNext Index dropped by 2.17% [1] - Total trading volume in the Shanghai and Shenzhen markets reached 16,770 billion, a decrease of 1,575 billion from the previous day [1] Banking Sector - The banking sector experienced a collective rebound, with major banks like Shanghai Bank and Chongqing Rural Commercial Bank rising over 3%, and others like Agricultural Bank and Industrial and Commercial Bank increasing by more than 2% [2] - The Central Economic Work Conference has set a favorable environment for banks to expand their balance sheets and provide long-term loans, while emphasizing the need to manage local and real estate risks [2] - According to CICC, listed banks are expected to see improved revenue and profit growth rates in 2026 and 2027 due to reduced net interest margin pressure and stable growth in fee income [2] - The average dividend yield for the banking sector is currently at 5.2%, significantly higher than the 10-year government bond yield, indicating a shift towards a "high dividend + high quality" investment cycle [2] AI Healthcare Sector - The AI healthcare sector saw strong gains, with stocks like Jiahe Meikang and Huaren Health hitting the daily limit of 20% increase, and others like Weining Health rising over 11% [3] - The Ant Group's AI health application "Antifufu" has seen a surge in downloads, reaching over 15 million monthly active users, indicating strong market interest [3] - The AI healthcare market in China has grown from 2 billion in 2019 to 6.4 billion in 2023, with projections to reach 224.4 billion by 2033, reflecting a compound annual growth rate of 43.1% [4] Commercial Aerospace Sector - The commercial aerospace sector experienced a surge, with companies like Xingchen Technology and Xice Testing hitting their daily limit, and others like Shunhao Co. and Tianjian Technology also seeing significant gains [5] - Xingchen Technology has reported successful delivery of products for commercial space applications, with plans for mass production starting in 2026 to meet increasing demand from private aerospace companies [6] - Recent policies and technological advancements are expected to accelerate the development of the commercial aerospace industry, with the National Space Administration promoting high-quality and safe development [7]

Core Insights - The Guangdong-Hong Kong-Macao Greater Bay Area Entrepreneurship Competition has successfully facilitated investment intentions exceeding 800 million yuan, highlighting the growing support for startups in the region [1] - The competition attracted over 7,000 projects, resulting in a total of 2.51 billion yuan in intended investments, showcasing the vibrant entrepreneurial ecosystem [1] Group 1: Government Support and Policies - The government has implemented a series of supportive policies for entrepreneurs, including tax incentives, administrative fee reductions, and increased loan limits for personal entrepreneurship [2][3] - The personal entrepreneurship guarantee loan limit has been raised from 50,000 yuan to 300,000 yuan, with some regions increasing it to 500,000 yuan, enhancing access to funding for startups [2] - Tax deduction limits have been increased from 8,000 yuan to 20,000 yuan, further easing the financial burden on small businesses [2] Group 2: Entrepreneurial Environment and Infrastructure - The number of entrepreneurial incubation bases in China has reached approximately 10,000, reflecting a growing infrastructure to support startups [3] - The Ministry of Human Resources and Social Security has conducted extensive entrepreneurial training, with an annual average of over 2 million participants, to enhance entrepreneurial skills [3] - Various entrepreneurial competitions and resource matching platforms have been established to connect entrepreneurs with funding and support services [4] Group 3: Future Directions and Initiatives - The government plans to strengthen targeted support for entrepreneurs by promoting various entrepreneurial models that align with market demands and development positioning [5] - A combination of policies, including one-time entrepreneurial subsidies and special loans for job stabilization, will continue to be implemented to support entrepreneurs and their projects [5]

Group 1 - The Guangdong-Hong Kong-Macao Greater Bay Area Entrepreneurship Competition attracted over 7,000 projects, resulting in a total investment intention of 2.51 billion yuan during the event [1] - Zhuhai Hengle Medical Technology Co., Ltd. won the gold award at the competition, securing over 80 million yuan in investment intentions from multiple investment institutions [1] - The competition featured five tracks, including artificial intelligence, robotics, pharmaceutical health, and biomanufacturing, highlighting the growth of new industries and business models in China [1] Group 2 - Zhanma Pharmaceutical (Zhongshan) Co., Ltd. has benefited from various government support policies, including 3 million yuan for innovation projects and 500,000 yuan for international academic conference funding [2] - The personal entrepreneurship guarantee loan limit has been increased from 50,000 yuan to 300,000 yuan, with some regions raising it to 500,000 yuan, enhancing financial support for entrepreneurs [2] - Tax incentives for small businesses and individual entrepreneurs have been improved, with the deduction limit raised from 8,000 yuan to 20,000 yuan [2] Group 3 - The number of entrepreneurship incubation bases in China has reached approximately 10,000, with significant growth in scale and quantity [3] - The Ministry of Human Resources and Social Security has conducted extensive entrepreneurship training, with an annual average of over 2 million participants [3] - The establishment of the "Malanhua Entrepreneurship Training" brand has led to the training of about 100,000 excellent instructors [3] Group 4 - Various entrepreneurship competitions are being held across the country, including those focused on women and e-commerce, fostering a supportive environment for startups [4] - The Ministry of Human Resources and Social Security has created a platform for entrepreneurship competitions, attracting over 210,000 projects and numerous entrepreneurs [4] - Future plans include enhancing targeted support for entrepreneurs and improving public entrepreneurship services to streamline processes [5]

文｜红餐网 "不喝蜜雪，不喝瑞幸，就要喝'哪吒仙饮'！" 最近，茶饮品牌"哪吒仙饮"在网络走红，但不是因为产品多好喝，而是其招商加盟引发的诸多争议。 多位哪吒仙饮加盟商曾连线博主"勇哥餐饮创业说"（下文简称为"勇哥"），讲述自己的开店经历。 有人直言自己花40多万成为了品牌区域代理，但门店开业短短8天就发现不对劲，怀疑自己入了快招圈套；也有连麦博主表示自己同样投入不少，目前每 天净亏几百元，但希望通过努力改善现状，让一众网友又急又气...... 哪吒仙饮，到底是"何方神圣"？ 投入40万开奶茶店，回本无望还要倒贴？ 连麦勇哥的哪吒仙饮加盟商，来自各地，背景也不尽相同，有不差钱的富二代，有一直梦想开一家奶茶店的宝妈，也有在职场辛苦打拼的年轻人。 今年9月，一位成都郫都区的女性加盟商连线勇哥，她原本经营一家小超市，但开奶茶店一直是她的梦想。 她告诉勇哥，最初，自己曾通过官网申请加盟蜜雪冰城，遭拒后，又辗转联系到一个自称"可操作加盟"的中介，但中介最终并没有帮她对接蜜雪冰城，而 是推荐了另一个品牌——哪吒仙饮。 尽管此前从未听过这个品牌，但招商人员描绘的"蓝图"让她动了心："一年开一店，三年开十店，打败蜜雪冰城"" ...

Group 1 - Shenzhen Dapu Microelectronics Co., Ltd. (referred to as "Dapu Micro") will be reviewed for its IPO application on December 25, 2025, making it the first unprofitable company to be considered for listing on the ChiNext board [1] - The China Securities Regulatory Commission (CSRC) announced the implementation of a third set of standards for the ChiNext board to support high-quality unprofitable innovative companies to go public [1] - Dapu Micro's initial public offering application was accepted by the Shenzhen Stock Exchange on June 27, 2025, marking it as the first unprofitable enterprise to be accepted for listing on the ChiNext board [1] Group 2 - Dapu Micro primarily engages in the research and sales of enterprise-level SSD products for data centers, being one of the few semiconductor storage providers in China with full-stack self-research capabilities in "controller chips + firmware algorithms + modules" [2] - The company focuses on enterprise-level SSD products, covering product generations from PCIe 3.0 to 5.0, and has laid out a comprehensive strategy around AI with large-capacity QLC SSDs, SCM SSDs, and computational storage SSDs [2] - During the reporting period, Dapu Micro's cumulative shipment of enterprise-level SSDs exceeded 4,900 PB, with over 75% of shipments featuring self-developed controller chips [2] - According to IDC data, Dapu Micro has maintained a leading market share in the domestic enterprise-level SSD market over the past three years [2] - The company's downstream clients include major internet, cloud computing, and AI companies such as Google, ByteDance, Tencent, Alibaba, JD.com, Baidu, Meituan, Kuaishou, Deepseek, Xiaohongshu, Didi, as well as server manufacturers and major telecommunications operators [2] - In 2025, Dapu Micro successfully passed tests from two leading global AI companies, Nvidia and xAI, indicating potential for increased production in the future [2]

Group 1 - The core point of the article is that Shangshui Intelligent's initial public offering (IPO) application has changed its review status to "submitted for registration" as of December 18, with the listing committee's approval date set for December 16, 2025 [1] - The company focuses on the manufacturing of new energy battery pole pieces and the preparation of new materials, specializing in the research, design, production, and sales of intelligent equipment with integrated process capabilities [1] - The company plans to raise 587 million yuan, which will be invested in the construction of a high-precision intelligent equipment manufacturing base in South China, a research and development center, and to supplement working capital [1] Group 2 - Financial data shows that the company achieved operating revenues of 397 million yuan, 601 million yuan, and 637 million yuan for the years 2022, 2023, and 2024, respectively [1] - The net profits for the same years were 97.72 million yuan, 234 million yuan, and 153 million yuan [1] - Key financial indicators for 2024 include an operating revenue of 636.59 million yuan, a net profit attributable to shareholders of 152.52 million yuan, and a basic earnings per share of 2.03 yuan [1]

本次冲击上市，尚水智能拟募集资金约5.87亿元，扣除发行费用后，将分别投资于高精智能装备华南总 部制造基地建设项目、研发中心建设项目、补充流动资金。 北京商报讯（记者 马换换 李佳雪）12月18日晚间，深交所官网显示，深圳市尚水智能股份有限公司 （以下简称"尚水智能"）创业板IPO提交注册。 据悉，尚水智能主营业务围绕微纳粉体处理、粉液精密计量、粉液混合分散、功能薄膜制备等核心工艺 环节展开，产品可广泛用于新能源电池、新材料、化工、食品、医药、半导体等行业。公司IPO于2025 年6月19日获得受理，2025年7月3日进入问询阶段，并于当年12月16日上会获得通过。 ...